Alpha Healthcare Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $100.00M |
---|---|
IPO Date | Sep 18, 2020 |
CEO | Rajiv Shukla |
Left Lead | Oppenheimer |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Healthcare in the United States |
IPO Geography | US/Canada |
Target Company | Humacyte |
Deal Announced | Feb 17, 2021 |
Deal Size, $M | $849.00M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | Aug 24, 2021 |
Amendment Vote | TBD |
Closing Date | Aug 26, 2021 |
Formerly AHAC
HUMA
HUMAW
Price | $4.13 |
---|---|
Last closing price | $4.27 |
H/L, today | $4.05 / $4.38 |
H/L, 52-week | $1.96 / $5.60 |
Volume, today | 1,818,363 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Alpha Healthcare Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 24 filings and events
- 2 underwriters
- 6 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Rajiv Shukla | 45 | Chairman, Chief Executive Officer and Director |
Patrick A. Sturgeon | 44 | Chief Financial Officer and Secretary |
Terrance L. Carlson | 67 | Director |
Brian Robertson | 50 | Director |
Bruce A. Springer | 50 | Director |
Kevin Xie | 50 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Oppenheimer | BR | 8,000,000 | units |
Northland Capital Markets | 2,000,000 | ||
10,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.